
1. elife. 2017 jan 9;6. pii: e15085. doi: 10.7554/elife.15085.

characterisation opposing effects g6pd deficiency cerebral malaria
and severe malarial anaemia.

clarke gm(1)(2), rockett k(1)(2)(3), kivinen k(3), hubbart c(1), jeffreys ae(1), 
rowlands k(1), jallow m(4)(5), conway dj(4)(6), bojang ka(4), pinder m(4), usen
s(4), sisay-joof f(4), sirugo g(4), toure o(7), thera ma(7), konate s(7), sissoko
s(7), niangaly a(7), poudiougou b(7), mangano vd(8), bougouma ec(9), sirima
sb(9), modiano d(8), amenga-etego ln(10), ghansah a(11), koram ka(11), wilson
md(11), enimil a(12), evans j(13)(14), amodu ok(15), olaniyan s(15), apinjoh
t(16), mugri r(17), ndi a(17), ndila cm(18), uyoga s(18), macharia a(18), peshu
n(18), williams tn(18)(19), manjurano a(20)(21), sep√∫lveda n(21), clark
tg(6)(21), riley e(21), drakeley c(20)(21), reyburn h(20)(21), nyirongo v(22),
kachala d(23), molyneux m(22)(24), dunstan sj(25), phu nh(23)(26), quyen nn(23), 
thai cq(23)(26), hien tt(23)(26)(27), manning l(27), laman m(27), siba p(27),
karunajeewa h(28), allen s(29), allen a(30), davis tm(28), michon p(27)(31),
mueller i(27)(32)(33), molloy sf(1), campino s(3), kerasidou a(1)(34), cornelius 
vj(1)(2), hart l(1), shah ss(1)(35), band g(1)(2), spencer cc(1), agbenyega
t(12)(36), achidi e(17), doumbo ok(7), farrar j(23)(37), marsh k(18), taylor
t(38), kwiatkowski dp(1)(2)(3); malariagen consortium(1)(3).

author information: 
(1)wellcome trust centre human genetics, university oxford, oxford, united
kingdom.
(2)mrc centre genomics global health, university oxford, oxford,
united kingdom.
(3)the wellcome trust sanger institute, cambridge, united kingdom.
(4)medical research council unit gambia, fajara, gambia.
(5)edward francis small teaching hospital, independence drive, banjul, gambia.
(6)department pathogen molecular biology, london school hygiene and
tropical medicine, london, united kingdom.
(7)malaria research training centre, university bamako, bamako, mali.
(8)university rome la sapienza, rome, italy.
(9)centre national de recherche et de formation sur le paludisme (cnrfp),
ouagadougou, burkina faso.
(10)navrongo health research centre, navrongo, ghana.
(11)noguchi memorial institute medical research, university ghana, accra, 
ghana.
(12)komfo anoyke teaching hospital, kumasi, ghana.
(13)department molecular medicine, bernhard nocht institute tropical
medicine, hamburg, germany.
(14)kumasi centre collaborative research, kumasi, ghana.
(15)university ibadan, ibadan, nigeria.
(16)department biochemistry molecular biology, university buea, buea,
cameroon.
(17)department medical laboratory sciences, university buea, buea,
cameroon.
(18)kemri-wellcome trust research programme, kilifi, kenya.
(19)department medicine, faculty medicine, imperial college, london, united
kingdom.
(20)joint malaria programme, kilimanjaro christian medical college, moshi,
tanzania.
(21)faculty infectious tropical diseases, london school hygiene and
tropical medicine, london, united kingdom.
(22)malawi-liverpool wellcome trust clinical research programme, university of
malawi, blantyre, malawi.
(23)oxford university clinical research unit, university oxford, ho chi minh
city, vietnam.
(24)liverpool school tropical medicine, pembroke place, liverpool, united
kingdom.
(25)the peter doherty institute infection immunity, university of
melbourne, melbourne, australia.
(26)hospital tropical diseases, ho chi minh city, viet nam.
(27)papua new guinea institute medical research, goroka, papua new guinea.
(28)university western australia, perth, australia.
(29)swansea university, swansea, united kingdom.
(30)weatherall institute molecular medicine, oxford university, oxford, united
kingdom.
(31)faculty medicine health sciences, divine word university, madang,
papua new guinea.
(32)walter eliza hall institute medical research, melbourne, australia.
(33)barcelona centre international health research, barcelona, spain.
(34)nuffield department population health, ethox centre, university of
oxford, oxford, united kingdom.
(35)laboratory malaria vector research, national institute allergy 
infectious diseases, national institutes health, bethesda, united states.
(36)kwame nkrumah university science technology, kumasi, ghana.
(37)nuffield department clinical medicine, center tropical medicine,
oxford university, oxford, united kingdom.
(38)blantyre malaria project college medicine, university malawi,
blantyre, malawi.

glucose-6-phosphate dehydrogenase (g6pd) deficiency believed confer
protection plasmodium falciparum malaria, precise nature the
protective effecthas proved difficult define g6pd deficiency multiple
allelic variants different effects males females, has
heterogeneous effects clinical outcome p. falciparum infection. we
report analysis multiple allelic forms g6pd deficiency large
multi-centre case-control study severe malaria, using classification
of g6pd mutations estimate individual's level enzyme activity from
their genotype. aggregated across genotypes, find increasing levels
of g6pd deficiency associated decreasing risk cerebral malaria, but
with increased risk severe malarial anaemia. models balancing selection
based findings indicate evolutionary trade-off different
clinical outcomes p. falciparum infection could major cause the
high levels g6pd polymorphism seen human populations.

doi: 10.7554/elife.15085 
pmcid: pmc5222559
pmid: 28067620  [indexed medline]

conflict interest statement: jf: director wellcome trust, one the
three founding funders elife. authors declare competing
interests exist.

